HomeCompareVPAHF vs MAIN

VPAHF vs MAIN: Dividend Comparison 2026

VPAHF yields 270.27% · MAIN yields 6.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPAHF wins by $716.54M in total portfolio value
10 years
VPAHF
VPAHF
● Live price
270.27%
Share price
$0.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$759.43M
Annual income
$439,524,286.02
Full VPAHF calculator →
MAIN
Main Street Capital Corporation
● Live price
6.91%
Share price
$52.96
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.89M
Annual income
$35,818,348.00
Full MAIN calculator →

Portfolio growth — VPAHF vs MAIN

📍 VPAHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPAHFMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPAHF + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VPAHF pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPAHF
Annual income on $10K today (after 15% tax)
$22,972.97/yr
After 10yr DRIP, annual income (after tax)
$373,595,643.12/yr
MAIN
Annual income on $10K today (after 15% tax)
$587.42/yr
After 10yr DRIP, annual income (after tax)
$30,445,595.80/yr
At 15% tax rate, VPAHF beats the other by $343,150,047.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPAHF + MAIN for your $10,000?

VPAHF: 50%MAIN: 50%
100% MAIN50/50100% VPAHF
Portfolio after 10yr
$401.16M
Annual income
$237,671,317.01/yr
Blended yield
59.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

VPAHF
No analyst data
Altman Z
2.9
Piotroski
3/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+23.2% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPAHF buys
0
MAIN buys
0
No recent congressional trades found for VPAHF or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPAHFMAIN
Forward yield270.27%6.91%
Annual dividend / share$2.00$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%72.7%
Portfolio after 10y$759.43M$42.89M
Annual income after 10y$439,524,286.02$35,818,348.00
Total dividends collected$726.21M$41.85M
Payment frequencyquarterlymonthly
SectorStockBDC

Year-by-year: VPAHF vs MAIN ($10,000, DRIP)

YearVPAHF PortfolioVPAHF Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$37,727$27,027.03$12,434$1,193.51+$25.3KVPAHF
2$135,662$95,294.33$16,255$2,280.05+$119.4KVPAHF
3$465,409$320,250.45$22,851$4,580.08+$442.6KVPAHF
4$1,524,778$1,026,790.34$35,577$9,892.59+$1.49MVPAHF
5$4,775,420$3,143,907.74$63,653$23,664.70+$4.71MVPAHF
6$14,311,885$9,202,185.51$136,601$65,054.52+$14.18MVPAHF
7$41,088,348$25,774,630.79$368,044$214,504.02+$40.72MVPAHF
8$113,120,635$69,156,102.86$1,301,668$887,987.40+$111.82MVPAHF
9$298,977,565$177,938,485.31$6,288,483$4,825,407.47+$292.69MVPAHF
10$759,430,280$439,524,286.02$42,886,603$35,818,348.00+$716.54MVPAHF

VPAHF vs MAIN: Complete Analysis 2026

VPAHFStock

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Full VPAHF Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this VPAHF vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPAHF vs SCHDVPAHF vs JEPIVPAHF vs OVPAHF vs KOVPAHF vs ARCCVPAHF vs HTGCVPAHF vs GBDCVPAHF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.